top of page
pexels-jopwell-2422293.jpg

About the Workshop

The IMPACT Collaboratory's mission is to build the nation’s capacity to conduct embedded pragmatic clinical trials (ePCTs) in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD). Training a workforce of investigators prepared to conduct ePCTs of non-pharmacological interventions embedded in healthcare systems is critical to this mission. The IMPACT Collaboratory holds an annual Training Workshop for program participants to develop competence in designing and conducting ePCTs of interventions to improve care for people living with dementia and their care partners.

This virtual 1.5-day workshop that will provide a foundation in practical aspects of designing and conducting ePCTs in AD/ADRD through a combination of panel discussions, small group sessions, and networking opportunities with experts in the field. Participants will gain knowledge in ePCT design and method, problem-solve challenges faced in current or planned projects, and network and engage with the larger community of IMPACT investigators. Throughout the program, special attention is paid to key considerations in designing ePCTs to ensure health equity.


Call for Applications for January 2024 Training Workshop

Wednesday, January 24th, 2024 | 11:00am - 3:30pm ET Thursday, January 25th, 2024 | 11:00am - 5:00pm ET

2024 Modules:

  • Understanding how to carry out sample size estimation for cluster randomized trials

  • Engaging people with lived experience and community partners in ePCTs for dementia

  • Partnering with your healthcare system for an ePCT

The IMPACT Collaboratory will hold the fourth annual Training Workshop on January 24-25, 2024 entitled Building Skills to Conduct Embedded Pragmatic Clinical Trials (ePCTs) among People Living with Dementia (PLWD) and their Care Partners. This 1.5-day virtual workshop features all new material to build a foundation in practical aspects of designing and conducting ePCTs in Alzheimer’s disease (AD) and AD-related dementias (ADRD). The workshop will include a combination of activities including: panel discussions, small group sessions, and networking opportunities with experts in the field.

We are inviting applications from early to mid-stage researchers who seek to develop competence in designing and conducting ePCTs of non-pharmacological interventions embedded in health care systems for PLWD and care partners.

Upon completion of the workshop, participants will be able to:

  • Transmit knowledge about designing and conducting ePCTs among PLWD and care partners in health care systems that integrates considerations related to estimating sample size requirements and establishing and sustaining key partnerships

  • Problem-solve common challenges in designing and conducting ePCTs for PLWD and care partners

  • Apply the acquired knowledge to move their current and future research in ePCTs forward, including applying for competitive funding

Successful applicants will be expected to complete selected readings and online training prior to the workshop. All participants are expected to attend and participate in the entire 1.5-day event.

All participants are expected to attend and participate in the entire 1.5-day event.


APPLICATIONS DUE: October 20, 2023 for the January 2024 Workshop.







  • Career Development Award Program. The NIA IMPACT Collaboratory will fund up to two career development awards (CDAs). These CDAs seek to support the development of early-stage MD, PhD, or equivalent researchers who seek careers conducting embedded pragmatic clinical trials (ePCTs) for people living with AD/ADRD and their care partners. Learn more and submit by September 15, 2023, at 5 PM ET.


  • Health Care System Scholars Program. The NIA IMPACT Collaboratory is issuing a call for Health Care Systems (HCS) Scholars. The HCS Scholars program offers researchers an opportunity to partner with healthcare systems to develop embedded pragmatic clinical trials (ePCTs) focused on improving the care provided to people living with dementia (PLWD) and their care partners (CPs). Learn more and submit a letter of intent by September 26, 2023 at 5 PM ET.


  • Call for Papers: Multidisciplinary Perspectives on Dementia and Population Health Trends. The TRENDS Network at the University of Michigan seeks manuscripts on the topic of dementia and population health trends for an upcoming Supplemental Issue in the Medical Sciences section of the Journal of Gerontology: Series A. Learn more and submit by October 1, 2023.


  • RFA-AG-24-030: Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional). Applications due October 30, 2023.

  • RFA-AG-24-031: Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional). Applications due October 30, 2023.

  • PAR-23-256: Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required). New and Renewal/Resubmission Applications due October 20, 2023 and AIDS applications due November 14,2023.

  • RFA-AG-24-050: Health Equity and the Cost of Novel Treatments for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed). Applications due October 31, 2023.

  • RFA-RM-23-012: Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional). Applications due October 31, 2023. Technical assistance webinar on September 6 at 2:00pm ET. Learn more and register on NOT-RM-23-023.

  • RFA-AG-24-029: Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD (R21 Clinical Trial Not Allowed). Applications due November 3, 2023.

  • NOT-AG-23-044: Notice of Intent to Publish a Funding Opportunity Announcement for High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional). First estimated application due date: November 1, 2023.

  • NOT-AG-23-040: Notice of Upcoming NIH Early Prediction of Alzheimer's Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) Open Innovation Challenge. First estimated application due date: January 31, 2024

  • RFA-AG-24-048: Primary Care-Based Screening Tool and Intervention Development for the Detection and Prevention of Abuse and Neglect in Older and Vulnerable Adults With, or at Risk for, Mild Cognitive Impairment and AD/ADRD (R61/R33 Clinical Trial Required). Applications due October 20, 2023.

bottom of page